{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:35:59Z","timestamp":1787499359272,"version":"build-2736575974"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004160","name":"Mazandaran University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004160","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbial Pathogenesis"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.micpath.2021.104764","type":"journal-article","created":{"date-parts":[[2021,2,5]],"date-time":"2021-02-05T07:05:11Z","timestamp":1612508711000},"page":"104764","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Protective efficacy by a novel multi-epitope vaccine, including MIC3, ROP8, and SAG1, against acute Toxoplasma gondii infection in BALB\/c mice"],"prefix":"10.1016","volume":"153","author":[{"given":"Samira","family":"Dodangeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8242-4880","authenticated-orcid":false,"given":"Mahdi","family":"Fasihi-Ramandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Daryani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Valadan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein","family":"Asgarian-Omran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Hosseininejad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tooran","family":"Nayeri Chegeni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdol Sattar","family":"Pagheh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javad","family":"Javidnia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahabeddin","family":"Sarvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.micpath.2021.104764_bib1","series-title":"Infectious Diseases of the Fetus and Newborn Infant","author":"Klein","year":"1983"},{"key":"10.1016\/j.micpath.2021.104764_bib2","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1590\/S0074-02762009000200029","article-title":"Why prevent, diagnose and treat congenital toxoplasmosis?","volume":"104","author":"McLeod","year":"2009","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.micpath.2021.104764_bib3","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1086\/501360","article-title":"Outcome of treatment for congenital toxoplasmosis, 1981\u20132004: the national collaborative Chicago-based, congenital toxoplasmosis study","volume":"42","author":"McLeod","year":"2006","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.micpath.2021.104764_bib4","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1093\/clinids\/18.1.38","article-title":"Early and longitudinal evaluations of treated infants and children and untreated historical patients with congenital toxoplasmosis: the Chicago Collaborative Treatment Trial","volume":"18","author":"McAuley","year":"1994","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.micpath.2021.104764_bib5","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1016\/S0264-410X(03)00163-4","article-title":"DNA vaccination with the immunodominant tachyzoite surface antigen (SAG-1) protects against adult acquired Toxoplasma gondii infection but does not prevent maternofoetal transmission","volume":"21","author":"Couper","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.micpath.2021.104764_bib6","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1186\/1756-3305-4-213","article-title":"DNA vaccination with a gene encoding Toxoplasma gondii GRA6 induces partial protection against toxoplasmosis in BALB\/c mice","volume":"4","author":"Sun","year":"2011","journal-title":"Parasites Vectors"},{"key":"10.1016\/j.micpath.2021.104764_bib7","doi-asserted-by":"crossref","first-page":"8838","DOI":"10.1016\/j.vaccine.2011.09.099","article-title":"Immunological responses induced by a DNA vaccine expressing RON4 and by immunogenic recombinant protein RON4 failed to protect mice against chronic toxoplasmosis","volume":"29","author":"Rashid","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.micpath.2021.104764_bib8","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1586\/14760584.2013.844652","article-title":"Vaccines against Toxoplasma gondii: new developments and perspectives","volume":"12","author":"Zhang","year":"2013","journal-title":"Expet Rev. Vaccine"},{"key":"10.1016\/j.micpath.2021.104764_bib9","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1128\/CVI.05578-11","article-title":"Vaccination with a DNA vaccine coding for perforin-like protein 1 and MIC6 induces significant protective immunity against Toxoplasma gondii","volume":"19","author":"Yan","year":"2012","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.micpath.2021.104764_bib10","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1007\/s00436-013-3425-0","article-title":"Evaluation of protective effect of multiantigenic DNA vaccine encoding MIC3 and ROP18 antigen segments of Toxoplasma gondii in mice","volume":"112","author":"Qu","year":"2013","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.micpath.2021.104764_bib11","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/1756-3305-6-63","article-title":"Compound DNA vaccine encoding SAG1\/SAG3 with A 2\/B subunit of cholera toxin as a genetic adjuvant protects BALB\/c mice against Toxoplasma gondii","volume":"6","author":"Cong","year":"2013","journal-title":"Parasites Vectors"},{"key":"10.1016\/j.micpath.2021.104764_bib12","doi-asserted-by":"crossref","first-page":"174","DOI":"10.5455\/javar.2019.f329","article-title":"Epitope-based vaccine as a universal vaccination strategy against Toxoplasma gondii infection: a mini-review","volume":"6","author":"Hajissa","year":"2019","journal-title":"J. Adv. Vet. Animal. Res."},{"key":"10.1016\/j.micpath.2021.104764_bib13","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.actatropica.2015.11.005","article-title":"Identification and characterization of epitopes on Plasmodium knowlesi merozoite surface protein-142 (MSP-142) using synthetic peptide library and phage display library","volume":"154","author":"Cheong","year":"2016","journal-title":"Acta Trop."},{"key":"10.1016\/j.micpath.2021.104764_bib14","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.cellimm.2007.02.005","article-title":"A systematic bioinformatics approach for selection of epitope-based vaccine targets","volume":"244","author":"Khan","year":"2006","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.micpath.2021.104764_bib15","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0923-2494(05)80097-5","article-title":"Role of P30 in host immunity and pathogenesis of T. gondii infection","volume":"144","author":"Kasper","year":"1993","journal-title":"Res. Immunol."},{"key":"10.1016\/j.micpath.2021.104764_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0063201","article-title":"Recombinant vaccines against T. gondii: comparison between homologous and heterologous vaccination protocols using two viral vectors expressing SAG1","volume":"8","author":"Mendes","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.micpath.2021.104764_bib17","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s10096-018-03442-6","article-title":"A systematic review on efficiency of microneme proteins to induce protective immunity against Toxoplasma gondii","volume":"38","author":"Dodangeh","year":"2019","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"10.1016\/j.micpath.2021.104764_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1756-3305-7-297","article-title":"Sero-diagnostic evaluation of Toxoplasma gondii recombinant Rhoptry antigen 8 expressed in E. coli","volume":"7","author":"Sonaimuthu","year":"2014","journal-title":"Parasites Vectors"},{"key":"10.1016\/j.micpath.2021.104764_bib19","doi-asserted-by":"crossref","first-page":"3977","DOI":"10.1016\/j.vaccine.2010.03.028","article-title":"Identification of T. gondii epitopes, adjuvants, and host genetic factors that influence protection of mice and humans","volume":"28","author":"Tan","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.micpath.2021.104764_bib20","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.micpath.2019.05.013","article-title":"In silico analysis and expression of a novel chimeric antigen as a vaccine candidate against Toxoplasma gondii","volume":"132","author":"Dodangeh","year":"2019","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.micpath.2021.104764_bib21","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.imlet.2017.03.006","article-title":"Enhancing immune responses to a DNA vaccine encoding Toxoplasma gondii GRA14 by calcium phosphate nanoparticles as an adjuvant","volume":"185","author":"Ahmadpour","year":"2017","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.micpath.2021.104764_bib22","doi-asserted-by":"crossref","first-page":"105696","DOI":"10.1016\/j.mimet.2019.105696","article-title":"A systematic review on the role of GRA proteins of Toxoplasma gondii in host immunization","volume":"165","author":"Rezaei","year":"2019","journal-title":"J. Microbiol. Methods"},{"key":"10.1016\/j.micpath.2021.104764_bib23","doi-asserted-by":"crossref","first-page":"101414","DOI":"10.1016\/j.cimid.2020.101414","article-title":"Toxoplasma gondii surface antigen 1 (SAG1) as a potential candidate to develop vaccine against toxoplasmosis: a systematic review","volume":"69","author":"Pagheh","year":"2020","journal-title":"Comp. Immunol. Microbiol. Infect. Dis."},{"key":"10.1016\/j.micpath.2021.104764_bib24","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0022-1759(02)00137-0","article-title":"The SPOT-synthesis technique: synthetic peptide arrays on membrane supports\u2014principles and applications","volume":"267","author":"Frank","year":"2002","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.micpath.2021.104764_bib25","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1590\/S0074-02762009000200019","article-title":"Vaccines against Toxoplasma gondii: challenges and opportunities","volume":"104","author":"Jongert","year":"2009","journal-title":"Mem\u00f3rias do instituto oswaldo cruz"},{"key":"10.1016\/j.micpath.2021.104764_bib26","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1038\/nm.3409","article-title":"Key roles of adjuvants in modern vaccines","volume":"19","author":"Reed","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.micpath.2021.104764_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0143087","article-title":"Vaccination with recombinant microneme proteins confers protection against experimental toxoplasmosis in mice","volume":"10","author":"Pinzan","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.micpath.2021.104764_bib28","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s00436-016-5325-6","article-title":"Immunological evaluation of a DNA cocktail vaccine with co-delivery of calcium phosphate nanoparticles (CaPNs) against the Toxoplasma gondii RH strain in BALB\/c mice","volume":"116","author":"Rahimi","year":"2017","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.micpath.2021.104764_bib29","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1080\/14760584.2017.1355733","article-title":"Calcium phosphate nanoparticles as a new generation vaccine adjuvant","volume":"16","author":"Lin","year":"2017","journal-title":"Expet Rev. Vaccine"},{"key":"10.1016\/j.micpath.2021.104764_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/0394632017742504","article-title":"Mannosylated T\/Tn with Freund's adjuvant induces cellular immunity","volume":"31","author":"Son","year":"2018","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"10.1016\/j.micpath.2021.104764_bib31","doi-asserted-by":"crossref","first-page":"6124","DOI":"10.1016\/j.vaccine.2018.08.068","article-title":"Characterization of a multi-epitope peptide with selective MHC-binding capabilities encapsulated in PLGA nanoparticles as a novel vaccine candidate against Toxoplasma gondii infection","volume":"36","author":"Roozbehani","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.micpath.2021.104764_bib32","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.micpath.2019.02.004","article-title":"Recombinant HcpA-EspA-Tir-Stx2B chimeric protein induces immunity against attachment and toxicity of Escherichia coli O157: H7","volume":"129","author":"Kordbacheh","year":"2019","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.micpath.2021.104764_bib33","doi-asserted-by":"crossref","first-page":"4054","DOI":"10.1016\/j.vaccine.2004.03.056","article-title":"Vaccination protects B cell-deficient mice against an oral challenge with mildly virulent Toxoplasma gondii","volume":"22","author":"Johnson","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.micpath.2021.104764_bib34","doi-asserted-by":"crossref","first-page":"103601","DOI":"10.1016\/j.micpath.2019.103601","article-title":"Protective efficacy induced by DNA prime and recombinant protein boost vaccination with Toxoplasma gondii GRA14 in mice","volume":"134","author":"Pagheh","year":"2019","journal-title":"Microb. Pathog."}],"container-title":["Microbial Pathogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088240102100036X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088240102100036X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:36:19Z","timestamp":1760110579000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S088240102100036X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":34,"alternative-id":["S088240102100036X"],"URL":"https:\/\/doi.org\/10.1016\/j.micpath.2021.104764","relation":{},"ISSN":["0882-4010"],"issn-type":[{"value":"0882-4010","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protective efficacy by a novel multi-epitope vaccine, including MIC3, ROP8, and SAG1, against acute Toxoplasma gondii infection in BALB\/c mice","name":"articletitle","label":"Article Title"},{"value":"Microbial Pathogenesis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micpath.2021.104764","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104764"}}